Opportunity Information: Apply for RFA HD 10 012

  • The National Institutes of Health in the health income security and social services sector is offering a public funding opportunity titled "Safe and Effective Instruments and Devices for Use in the Neonatal Intensive Care Units (SBIR R43)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.173 Research Related to Deafness and Communication Disorders 93.838 Lung Diseases Research 93.865 Child Health and Human Development Extramural Research.
  • This funding opportunity was created on Jul 16, 2010 and posted on Jul 16, 2010.
  • Applicants must submit their applications by Sep 17, 2010. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $900,000.00 to eligible and selected applicants.
  • Each selected applicant is eligible to receive up to $225,000.00 in funding.
  • Eligible applicants include: Small businesses.
Apply for RFA HD 10 012

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The Safe and Effective Instruments and Devices for Use in the Neonatal Intensive Care Units (SBIR R43) opportunity (Funding Opportunity Number RFA-HD-10-012) is a National Institutes of Health (NIH) small business grant aimed at improving how clinicians monitor and treat newborn infants and young children in neonatal intensive care units (NICUs). The core focus is on device and instrument innovation: applicants are expected to propose early-stage research that either creates new tools or meaningfully improves existing ones so they can be used more safely and effectively with fragile neonatal and pediatric patients. The intent is practical and clinically grounded, centering on technologies that address the unique challenges of caring for premature and critically ill infants, where standard medical devices may be too large, too invasive, insufficiently accurate, or not designed around neonatal physiology and safety requirements.

This funding announcement uses the SBIR Phase I grant mechanism (R43). That detail matters because it signals that the program is meant to support feasibility and proof-of-concept work rather than later-stage product development. In other words, it is structured for small businesses that have a strong technical idea and need resources to demonstrate that the concept can work, that it can be engineered toward a device suitable for NICU use, and that it shows promise for safety and efficacy. The announcement explicitly does not support SBIR Phase II, Fast Track, or Phase II Competing Renewal applications under this FOA, so companies seeking follow-on development would need to look to other mechanisms or future opportunities for later-stage funding.

The FOA runs in parallel with a closely related announcement of the same scientific scope under the STTR program (R41), identified as RFA-HD-10-013. Practically, that parallel structure gives small companies two pathways depending on how they plan to organize the work: SBIR is generally centered on the small business performing most of the R and D internally (with permitted subcontracting), while STTR is designed around a formal collaboration between a small business and a non-profit research institution. The science goals are aligned; the difference is the business-research partnership structure and eligibility requirements tied to the mechanism.

Eligibility is limited to small business concerns, and there is no cost sharing or matching requirement, which reduces barriers for early-stage firms and startups that may not have large pools of discretionary capital. The opportunity is categorized as discretionary grant funding in the health domain, and it is associated with multiple CFDA numbers reflecting the NIH institutes involved and their mission areas: 93.865 (Child Health and Human Development Extramural Research), 93.838 (Lung Diseases Research), and 93.173 (Research Related to Deafness and Communication Disorders). Those codes also hint at the kinds of NICU-related device problems that may be especially relevant, including neonatal respiratory support and monitoring, and potentially technologies affecting hearing and communication-related outcomes in infants.

In terms of funding scale and competition, the announcement describes set-aside funds and an anticipated number of awards for fiscal year 2011 across participating NIH institutes. The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) set aside $900,000 to support up to four meritorious applications, the National Heart, Lung, and Blood Institute (NHLBI) set aside another $900,000 to support up to four meritorious applications, and the National Institute on Deafness and Other Communication Disorders (NIDCD) set aside $225,000 to support one meritorious application. The award ceiling listed is $225,000, consistent with typical SBIR Phase I budget expectations. The announcement also notes that future year funding levels depend on annual appropriations, meaning the amounts and number of awards could change based on federal budget decisions beyond that fiscal year.

Key dates included a posted and created date of July 16, 2010, an original and current closing date of September 17, 2010, and an archive date of October 18, 2010. While those dates indicate this specific solicitation cycle is no longer active, the summary still reflects the program’s intent and structure, which can be useful for understanding NIH’s priorities for NICU device innovation and for tracking similar or successor opportunities.

Overall, this FOA is designed to push forward the early engineering and feasibility research needed to bring safer, more effective neonatal and pediatric monitoring and treatment devices closer to clinical reality, using a small business-led innovation model. Applicants are expected to align their proposed technology development with real NICU constraints, including patient fragility, safety margins, clinical workflow, and the need for accurate, reliable measurements or therapies in very small patients, while producing Phase I results that justify further development and eventual translation into NICU practice.

Frequently Asked Questions (FAQs)

What is the name of this grant opportunity?

The opportunity is titled "Safe and Effective Instruments and Devices for Use in the Neonatal Intensive Care Units (SBIR R43)".

What is the Funding Opportunity Number (FOA number)?

The Funding Opportunity Number is RFA-HD-10-012.

Who is the sponsoring agency?

This is a National Institutes of Health (NIH) funding opportunity.

What kind of program is this (SBIR or STTR)?

This announcement uses the SBIR program and specifically the SBIR Phase I (R43) grant mechanism.

What is the main purpose of the FOA?

The FOA aims to improve how clinicians monitor and treat newborn infants and young children in neonatal intensive care units (NICUs) by supporting innovation in instruments and devices that are safer and more effective for fragile neonatal and pediatric patients.

What types of projects does this FOA support?

The FOA supports early-stage research focused on creating new tools or meaningfully improving existing devices/instruments so they can be used more safely and effectively with neonatal and pediatric patients in NICU settings.

What makes NICU device innovation a focus here?

The FOA is motivated by the practical reality that standard medical devices may be too large, too invasive, not accurate enough, or not designed for neonatal physiology and safety requirements when used with premature or critically ill infants.

Is this funding intended for feasibility work or later-stage development?

This is an SBIR Phase I (R43) opportunity, so it is structured to support feasibility and proof-of-concept work rather than later-stage product development.

Does this FOA support SBIR Phase II, Fast Track, or Phase II Competing Renewals?

No. The announcement explicitly states it does not support SBIR Phase II, Fast Track, or Phase II Competing Renewal applications under this FOA.

If a company wants follow-on development funding, can they apply for Phase II under this same FOA?

No. Companies seeking follow-on development would need to pursue other mechanisms or future opportunities for later-stage funding, since this FOA is limited to SBIR Phase I (R43) only.

Who is eligible to apply?

Eligibility is limited to small business concerns.

Is cost sharing or matching required?

No. The FOA states there is no cost sharing or matching requirement.

What is the related STTR opportunity and how is it different?

A parallel announcement with the same scientific scope exists under STTR: RFA-HD-10-013 (STTR R41). The scientific goals are aligned, but the difference is structural: SBIR is generally centered on the small business conducting most R&D internally (with permitted subcontracting), while STTR is designed around a formal collaboration between a small business and a non-profit research institution.

What is the maximum award amount mentioned in the FOA?

The award ceiling listed is $225,000, consistent with typical SBIR Phase I budget expectations.

Which NIH institutes set aside funds for this FOA and how much?

For fiscal year 2011, the FOA describes set-aside funds across participating NIH institutes:

  • NICHD: $900,000 to support up to four meritorious applications
  • NHLBI: $900,000 to support up to four meritorious applications
  • NIDCD: $225,000 to support one meritorious application

How many awards were anticipated?

The FOA anticipated up to:

  • 4 awards supported by NICHD set-aside funds
  • 4 awards supported by NHLBI set-aside funds
  • 1 award supported by NIDCD set-aside funds

These are described as support for meritorious applications for fiscal year 2011.

Are the listed funding levels guaranteed in future years?

No. The FOA notes that future year funding levels depend on annual appropriations, meaning funding amounts and the number of awards could change based on federal budget decisions beyond that fiscal year.

What CFDA numbers are associated with this opportunity?

The FOA is associated with multiple CFDA numbers reflecting participating NIH institutes and mission areas:

  • 93.865 (Child Health and Human Development Extramural Research)
  • 93.838 (Lung Diseases Research)
  • 93.173 (Research Related to Deafness and Communication Disorders)

What types of NICU-related device problems seem especially relevant based on the CFDA codes?

Based on the CFDA associations described, relevant areas may include NICU-related device challenges tied to neonatal respiratory support and monitoring and potentially technologies affecting hearing and communication-related outcomes in infants, alongside broader child health and development needs.

What are the important dates for this FOA?

  • Posted/Created date: July 16, 2010
  • Original and current closing date: September 17, 2010
  • Archive date: October 18, 2010

Is this specific solicitation cycle still open?

No. The closing and archive dates indicate this specific solicitation cycle is no longer active.

Why might this archived FOA still be useful to read?

Even though it is no longer active, the FOA summary still reflects NIH program intent and structure. That can be useful for understanding NIH priorities around NICU device innovation and for tracking similar or successor opportunities.

What kind of outcomes is NIH looking for in Phase I under this FOA?

The FOA emphasizes Phase I results that demonstrate a concept can work and can be engineered toward a NICU-suitable device, with promise for safety and efficacy, and with development grounded in real NICU constraints.

What NICU constraints should applicants design around according to the FOA summary?

The FOA highlights practical, clinically grounded constraints including:

  • Patient fragility and narrow safety margins
  • Clinical workflow in the NICU environment
  • The need for accurate, reliable measurements or therapies in very small patients
  • Devices being appropriately designed for neonatal physiology and safety requirements
Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health Income Security and Social Services

Next opportunity: Safe and Effective Instruments and Devices for Use in the Neonatal Intensive Care Units (STTR R41)

Previous opportunity: Community based HIV/AIDS Prevention Angola

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA HD 10 012

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA HD 10 012) also looked into and applied for these:

Funding Opportunity
Safe and Effective Instruments and Devices for Use in the Neonatal Intensive Care Units (STTR R41) Apply for RFA HD 10 013

Funding Number: RFA HD 10 013
Agency: National Institutes of Health
Category: Health Income Security and Social Services
Funding Amount: $225,000
Innovative Therapies and Tools for Screenable Disorders in Newborns (R03) Apply for PAR 10 231

Funding Number: PAR 10 231
Agency: National Institutes of Health
Category: Health Income Security and Social Services
Funding Amount: Case Dependent
Developmental Mechanisms of Human Structural Birth Defects (P01) Apply for RFA HD 10 006

Funding Number: RFA HD 10 006
Agency: National Institutes of Health
Category: Health Income Security and Social Services
Funding Amount: $900,000
NICHD Program Project Grant (P01) Apply for PAR 10 245

Funding Number: PAR 10 245
Agency: National Institutes of Health
Category: Health Income Security and Social Services
Funding Amount: Case Dependent
Molecular Mechanisms of Adverse Metabolic Drug Effects in Children and Adolescents (R01) Apply for RFA HD 10 010

Funding Number: RFA HD 10 010
Agency: National Institutes of Health
Category: Health Income Security and Social Services
Funding Amount: $250,000
Dual Purpose with Dual Benefit Research in Biomedicine and Agriculture Using Agriculturally Important Domestic Species (R01) Apply for PAR 10 276

Funding Number: PAR 10 276
Agency: National Institutes of Health
Category: Health Income Security and Social Services
Funding Amount: Case Dependent
Identifying and Understanding Effective Interventions for Orphans and Vulnerable Children Affected by HIV/AIDS (R01) Apply for RFA HD 10 017

Funding Number: RFA HD 10 017
Agency: National Institutes of Health
Category: Health Income Security and Social Services
Funding Amount: Case Dependent
Preclinical Research on Model Organisms to Predict Treatment Outcomes for Disorders Associated with Intellectual and Developmental Disabilities (R01) Apply for PAR 11 038

Funding Number: PAR 11 038
Agency: National Institutes of Health
Category: Health Income Security and Social Services
Funding Amount: Case Dependent
Understanding and Treating Co Morbid Conditions in Adolescents with Intellectual and Developmental Disabilities (R01) Apply for PA 11 039

Funding Number: PA 11 039
Agency: National Institutes of Health
Category: Health Income Security and Social Services
Funding Amount: Case Dependent
Understanding and Treating Co Morbid Conditions in Adolescents with Intellectual and Developmental Disabilities (R03) Apply for PA 11 040

Funding Number: PA 11 040
Agency: National Institutes of Health
Category: Health Income Security and Social Services
Funding Amount: Case Dependent
Understanding and Treating Co Morbid Conditions in Adolescents with Intellectual and Developmental Disabilities (R21) Apply for PA 11 041

Funding Number: PA 11 041
Agency: National Institutes of Health
Category: Health Income Security and Social Services
Funding Amount: $200,000
Specialized Cooperative Centers Program in Reproduction and Infertility Research (U54) Apply for RFA HD 12 169

Funding Number: RFA HD 12 169
Agency: National Institutes of Health
Category: Health Income Security and Social Services
Funding Amount: Case Dependent
Outcome Measures for Use in Treatment Trials for Individuals with Intellectual and Developmental Disabilities (R01) Apply for PAR 11 045

Funding Number: PAR 11 045
Agency: National Institutes of Health
Category: Health Income Security and Social Services
Funding Amount: Case Dependent
Indo US Collaborative Program on Low Cost Medical Devices (R03) Apply for PAR 11 044

Funding Number: PAR 11 044
Agency: National Institutes of Health
Category: Health Income Security and Social Services
Funding Amount: Case Dependent
Mechanisms of Adverse Drug Reactions in Children (R01) Apply for PAR 11 051

Funding Number: PAR 11 051
Agency: National Institutes of Health
Category: Health Income Security and Social Services
Funding Amount: Case Dependent
Mechanisms of Adverse Drug Reactions in Children (R03) Apply for PAR 11 052

Funding Number: PAR 11 052
Agency: National Institutes of Health
Category: Health Income Security and Social Services
Funding Amount: Case Dependent
Studies in Neonatal Hypoglycemia (R03) Apply for PA 11 054

Funding Number: PA 11 054
Agency: National Institutes of Health
Category: Health Income Security and Social Services
Funding Amount: Case Dependent
Studies in Neonatal Hypoglycemia (R01) Apply for PA 11 053

Funding Number: PA 11 053
Agency: National Institutes of Health
Category: Health Income Security and Social Services
Funding Amount: Case Dependent
Studies in Neonatal Hypoglycemia (R21) Apply for PA 11 055

Funding Number: PA 11 055
Agency: National Institutes of Health
Category: Health Income Security and Social Services
Funding Amount: $200,000
Mentored Patient Oriented Research Career Development Award in Muscular Dystrophy Research (K23) Apply for PA 11 076

Funding Number: PA 11 076
Agency: National Institutes of Health
Category: Health Income Security and Social Services
Funding Amount: Case Dependent

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA HD 10 012", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.